Page last updated: 2024-09-03

peroxynitrous acid and rasagiline

peroxynitrous acid has been researched along with rasagiline in 1 studies

Compound Research Comparison

Studies
(peroxynitrous acid)
Trials
(peroxynitrous acid)
Recent Studies (post-2010)
(peroxynitrous acid)
Studies
(rasagiline)
Trials
(rasagiline)
Recent Studies (post-2010) (rasagiline)
3,303211,23053572314

Protein Interaction Comparison

ProteinTaxonomyperoxynitrous acid (IC50)rasagiline (IC50)
CholinesteraseHomo sapiens (human)2.3865
Amine oxidase [flavin-containing] BRattus norvegicus (Norway rat)1.0029
Amine oxidase [flavin-containing] A Rattus norvegicus (Norway rat)0.2115
Amine oxidase [flavin-containing] AHomo sapiens (human)1.088
AcetylcholinesteraseHomo sapiens (human)0.019
Amine oxidase [flavin-containing] BHomo sapiens (human)0.2217

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Maruyama, W; Naoi, M; Takahashi, T; Youdim, M1

Other Studies

1 other study(ies) available for peroxynitrous acid and rasagiline

ArticleYear
The anti-Parkinson drug, rasagiline, prevents apoptotic DNA damage induced by peroxynitrite in human dopaminergic neuroblastoma SH-SY5Y cells.
    Journal of neural transmission (Vienna, Austria : 1996), 2002, Volume: 109, Issue:4

    Topics: Antiparkinson Agents; Apoptosis; DNA Damage; Dopamine; Humans; Indans; Membrane Potentials; Mitochondria; Neuroblastoma; Neuroprotective Agents; Peroxynitrous Acid; Structure-Activity Relationship; Tumor Cells, Cultured

2002